✦ LIBER ✦

Clinical and pharmacokinetic study of 96-h infusions of doxorubicin in advanced cancer patients

✍ Scribed by Bugat, R.; Robert, J.; Herrera, A.; Pinel, M.C.; Huet, S.; Chevreau, C.; Boussin, G.; Roquain, J.; Carton, M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I clinical and pharmacokinetic stu

✍ C. Sessa; A. Perotti; C. Noberasco; F. De Braud; E. Gallerani; S. Cresta; M. Zuc 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 185 KB

Phase I dose escalation and pharmacokine

✍ Danson, S; Ferry, D; Alakhov, V; Margison, J; Kerr, D; Jowle, D; Brampton, M; Ha 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 120 KB

Pharmacokinetics and metabolism of doxor

✍ Anders Andersen; Harald Holte; Lars Slørdal 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 108 KB

959 Comparison of pharmacokinetics (PK)

✍ J. Schüller; M Czejka; S. Bandak; D. Borow; C. Pietrzak; I. Marei; G. Schernthan 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 157 KB

Pharmacokinetic and clinical studies of

✍ Harvey J. Cohen; Norman Jaffe 📂 Article 📅 1978 🏛 Springer 🌐 English ⚖ 364 KB

Dose-finding phase I study of simultaneo

✍ Y. Ito; K. Aiba; N. Horikoshi; T. Saotome; T. Irie; K. Sugiyama; M. Nakane; D. H 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 87 KB